日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology

DNA和RNA谱分析的一致性分析:MD安德森癌症中心IMPACT2精准肿瘤学研究

Schmidt, Stephanie T; Baysal, Mehmet A; Fu, Siqing; Hong, David S; Piha-Paul, Sarina A; Naing, Aung; Rodon Ahnert, Jordi; Yap, Timothy A; Dumbrava, Ecaterina Elena; Beck, Jennifer; Meric-Bernstam, Funda; Tsimberidou, Apostolia Maria

Advances in multiple myeloma: key updates from the ASH 2025 meeting

多发性骨髓瘤研究进展:ASH 2025 会议的主要更新

Naing, Phyu Thin; Baljevic, Muhamed

DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix

DART/SWOG/NCI II期抗CTLA-4/PD-1试验:卵巢、子宫内膜、宫颈透明细胞癌

Chae, Young Kwang; Othus, Megan; Patel, Sandip P; Backes, Floortje J; O'Malley, David M; Cristea, Mihaela; Naing, Aung; Kurnit, Katherine; Eskander, Ramez N; T Goodrich, Scott; Robinson, William R; Scalici, Jennifer; Chan, John; Ali-Ahmad, Hussein; Hays, John; McCormick, Colleen; Kim, Edward J; Sueblinvong, Thanasak; Ahmed, Amina; Siedel, Jean; Thomes Pepin, Jessica; Bottsford-Miller, Justin Neal; Fagbemi, Seth Olusegun; Jaslowski, Anthony John; Kim, Hye Sung; Chung, Liam Il-Young; Moloney-Lineen, Carolyn; McLeod, Christine M; Chen, Helen X; Sharon, Elad; Streicher, Howard; Ryan, Christopher W; Blanke, Charles D; Kurzrock, Razelle

Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson

在MD安德森癌症中心早期临床试验中入组的晚期非小细胞肺癌患者的治疗反应

Lim, Jeong Uk; Lin, Heather Y; Kang, Lei; Le, Hung; Tang, Tin-Yun; Champiat, Stephane; Dumbrava, Ecaterina Elena; Le, Xiuning; Naing, Aung; Piha-Paul, Sarina A; Ahnert, Jordi Rodon; Tsimberidou, Apostolia Maria; Yap, Timothy A; Fu, Siqing; Meric-Bernstam, Funda; Hong, David S

Transformer-Based Deep Learning Approaches for Speech-Based Dementia Detection: A Systematic Review

基于Transformer的深度学习方法在语音痴呆症检测中的应用:系统性综述

Mobtahej, Pooyan; Gouron, Sam T; Javaheri, Rojan; Le, Dennis N; El-Khoury, Annelisse; Naing, Thiri Htet; Sajjadi, S Ahmad

Unraveling the Genetic Architecture of Photoperiod Sensitivity in Myanmar Rice Landraces Through Integrated GWAS and Transcriptome Analysis

通过整合全基因组关联分析和转录组分析揭示缅甸水稻地方品种光周期敏感性的遗传结构

Naing, Nant Nyein Zar Ni; Zhu, Qian; Wang, Chunli; Zhou, Xiaoli; Zhang, Cui; Li, Junjie; Wang, Xianyu; Yin, Yushan; Zhao, Xiaolong; Wen, Jiancheng; Lee, Dongsun; Chen, Lijuan

Impact of reducing colistin use on colistin resistance in Escherichia coli isolated from humans and poultry in Indonesia (COINCIDE): A protocol for a multisectoral, transdisciplinary One Health study

减少粘菌素使用对印度尼西亚人和家禽分离的大肠杆菌粘菌素耐药性的影响(COINCIDE):一项多部门、跨学科的“同一健康”研究方案

Naing, Soe Yu; Severin, Juliëtte; Zomer, Aldert; Kuntaman, Kuntaman; Suandy, Imron; Sunandar, Sunandar; Rachmawati, Annisa; Nurbiyanti, Nofita; Schneiders, Mira Leonie; Grietens, Koen Peeters; Widya, Alicia; van der Graaf-van Bloois, Linda; Pruvot, Mathieu; Nobrega, Diego; Karuniawati, Anis; Wagenaar, Jaap A

Phase I study of bevacizumab and temsirolimus combination therapy in advanced malignancies: safety, efficacy, and ovarian cancer expansion

贝伐珠单抗联合替西罗莫司治疗晚期恶性肿瘤的I期研究:安全性、疗效及卵巢癌扩展研究

Piha-Paul, Sarina A; Tseng, Chieh; Thompson, Emily; Stafford, R Jason; Le, Hung; Kang, Lei; Fu, Siqing; Tsimberidou, Apostolia; Blumenschein, George; Ahnert, Jordi Rodon; Slopis, John M; Hong, David; Naing, Aung; Meric-Bernstam, Funda; Ng, Chaan S; Westin, Shannon; Sood, Anil K

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity

远程医疗作为早期肿瘤临床试验的途径:来自14000名患者的经验教训以及全球可及性和公平性的未来方向

Torrado, Carlos; Andersen, Clark R; Kang, Lei; Brink, Amanda L; Adesoye, Taiwo; Le, Hung; Patterson, Clover J; Poullard, Anna; Osburn, Jessica A; Tan, Harold N; Gouda, Mohamed A; Charles, Sheena; Urschel, Gabriele E; Tang, Tin-Yun; Hong, David S; Champiat, Stephane; Naing, Aung; Tsimberidou, Apostolia M; Dumbrava, Ecaterina E; Piha-Paul, Sarina A; Rodon, Jordi; Yap, Timothy A; Pohlmann, Paula R; Meric-Bernstam, Funda; Fu, Siqing

First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies

KPT-9274(一种首创的PAK4和NAMPT双重抑制剂)在晚期实体恶性肿瘤患者中的首次人体I期研究

Razak, Albiruni; Mahipal, Amit; Diamond, Jennifer R; Ribas, Antoni; Berlin, Jordan David; Azmi, Asfar S; Mark, Tomer; Walker, Christopher J; Chai, Yi; Kashyap, Trinayan; Gudi, Girish; Naing, Aung